Chemoinformaics analysis of Kaempferol 3-O-arabinoside
| Molecular Weight | 418.354 | nRot | 3 |
| Heavy Atom Molecular Weight | 400.21 | nRig | 2 |
| Exact Molecular Weight | 418.09 | nRing | 4 |
| Solubility: LogS | -3.227 | nHRing | 2 |
| Solubility: LogP | 3.774 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 17 |
| nHA | 10 | APOL | 53.4223 |
| nHD | 6 | BPOL | 24.1337 |
| QED | 0.313 |
| Synth | 2.305 |
| Natural Product Likeliness | 2.024 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.003 |
| HIA | 0.006 |
| CACO-2 | -4.438 |
| MDCK | 0.0000264 |
| BBB | 0.997 |
| PPB | 0.906655 |
| VDSS | 1.089 |
| FU | 0.0949563 |
| CYP1A2-inh | 0.935 |
| CYP1A2-sub | 0.693 |
| CYP2c19-inh | 0.599 |
| CYP2c19-sub | 0.805 |
| CYP2c9-inh | 0.307 |
| CYP2c9-sub | 0.926 |
| CYP2d6-inh | 0.063 |
| CYP2d6-sub | 0.524 |
| CYP3a4-inh | 0.083 |
| CYP3a4-sub | 0.144 |
| CL | 3.414 |
| T12 | 0.535 |
| hERG | 0.025 |
| Ames | 0.254 |
| ROA | 0.805 |
| SkinSen | 0.969 |
| Carcinogencity | 0.718 |
| EI | 0.983 |
| Respiratory | 0.963 |
| NR-Aromatase | 0.015 |
| Antiviral | Yes |
| Prediction | 0.916598 |